Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Current Trends in the Treatment and Prevention of Opportunistic Infections

Current Trends in the Treatment and Prevention of Opportunistic Infections Current Trends in the Treatment and Prevention of Opportunistic Infections • • • By Mark L. Tuerst provide widespread prophylaxis for TB regardless of skin test positivity. The with Clinical Research on AIDS is now examining the issue of isoniazid (INH) prophylaxis tages of dapsone and pyrimethamine, such as Community Programs prevention of opportunistic infections (OIs) is a major concern both for patients infected with HIV and for their physicians. In the absence of longterm, effective, antiretroviral therapy, there is no known alternative to improve the immune deficit of AIDS patients. Prevention of OIs may lead to an increase in the survival and the quality of patients' lives. The first condition required for OI prophylaxis is to recognize the target population. The prophylactic regimen chosen must have some optimal effect on most of the strains responsible for the OI. The drug must also be well-tolerated with very specific effects, and should be able to eradicate the infection. Such an agent for one OI may also help to prevent other types of infection, either bacterial or parasitic. The total number of CD4 positive lymphocytes is often helpful in correlating the occurrence of a specific OI. Tuberculosis (TB) is most http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AIDS Patient Care Mary Ann Liebert

Current Trends in the Treatment and Prevention of Opportunistic Infections

AIDS Patient Care , Volume 7 (1) – Feb 1, 1993

Current Trends in the Treatment and Prevention of Opportunistic Infections

AIDS Patient Care , Volume 7 (1) – Feb 1, 1993

Abstract

Current Trends in the Treatment and Prevention of Opportunistic Infections • • • By Mark L. Tuerst provide widespread prophylaxis for TB regardless of skin test positivity. The with Clinical Research on AIDS is now examining the issue of isoniazid (INH) prophylaxis tages of dapsone and pyrimethamine, such as Community Programs prevention of opportunistic infections (OIs) is a major concern both for patients infected with HIV and for their physicians. In the absence of longterm, effective, antiretroviral therapy, there is no known alternative to improve the immune deficit of AIDS patients. Prevention of OIs may lead to an increase in the survival and the quality of patients' lives. The first condition required for OI prophylaxis is to recognize the target population. The prophylactic regimen chosen must have some optimal effect on most of the strains responsible for the OI. The drug must also be well-tolerated with very specific effects, and should be able to eradicate the infection. Such an agent for one OI may also help to prevent other types of infection, either bacterial or parasitic. The total number of CD4 positive lymphocytes is often helpful in correlating the occurrence of a specific OI. Tuberculosis (TB) is most

Loading next page...
 
/lp/mary-ann-liebert/current-trends-in-the-treatment-and-prevention-of-opportunistic-ifV0aEkaVx
Publisher
Mary Ann Liebert
Copyright
Copyright 1993 Mary Ann Liebert, Inc.
ISSN
0893-5068
eISSN
1557-7449
DOI
10.1089/apc.1993.7.38
Publisher site
See Article on Publisher Site

Abstract

Current Trends in the Treatment and Prevention of Opportunistic Infections • • • By Mark L. Tuerst provide widespread prophylaxis for TB regardless of skin test positivity. The with Clinical Research on AIDS is now examining the issue of isoniazid (INH) prophylaxis tages of dapsone and pyrimethamine, such as Community Programs prevention of opportunistic infections (OIs) is a major concern both for patients infected with HIV and for their physicians. In the absence of longterm, effective, antiretroviral therapy, there is no known alternative to improve the immune deficit of AIDS patients. Prevention of OIs may lead to an increase in the survival and the quality of patients' lives. The first condition required for OI prophylaxis is to recognize the target population. The prophylactic regimen chosen must have some optimal effect on most of the strains responsible for the OI. The drug must also be well-tolerated with very specific effects, and should be able to eradicate the infection. Such an agent for one OI may also help to prevent other types of infection, either bacterial or parasitic. The total number of CD4 positive lymphocytes is often helpful in correlating the occurrence of a specific OI. Tuberculosis (TB) is most

Journal

AIDS Patient CareMary Ann Liebert

Published: Feb 1, 1993

There are no references for this article.